MetaADEDB 2.0 @ LMMD
ciclesonide
(LUKZNWIVRBCLON-GXOBDPJESA-N)
Structure
SMILES
O=C(C(C)C)OCC(=O)[C@@]12O[C@@H](O[C@@H]1C[C@@H]1[C@]2(C)C[C@H](O)[C@H]2[C@H]1CCC1=CC(=O)C=C[C@]21C)C1CCCCC1
Type(s)
Approved; Investigational
ATC code(s)
R01AD13; R03BA08
Molecular Formula:
C32H44O7
Molecular Weight:
540.688
Log P:
4.7039
Hydrogen Bond Acceptor:
7
Hydrogen Bond Donor:
1
TPSA:
99.13
CAS Number(s):
126544-47-6; 141845-82-1
Synonym(s)
1.
ciclesonide
2.
(R)-11beta,16alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with cyclohexanecarboxaldehyde, 21-isobutyrate
3.
Alvesco
4.
Omnaris
External Link(s)
MeSHC120481
PubChem Compound6918155
BindingDB50247997
ChEBI31397
CHEMBLCHEMBL2040682
DrugBankDB01410
DrugCentral633
IUPHAR/BPS Guide to PHARMACOLOGY7469
KEGGdr:D01703
Therapeutic Target DatabaseD0K7HU
ZINC3915154
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1HeadacheFAERS: 15
Canada Vigilance: 7
Canada Vigilance
SIDER
US FAERS
2Drug ineffectiveFAERS: 9
Canada Vigilance: 34
Canada Vigilance
US FAERS
3HypersensitivityFAERS: 9
Canada Vigilance: 5
Canada Vigilance
US FAERS
4AsthmaFAERS: 8
Canada Vigilance: 6
Canada Vigilance
OFFSIDES
US FAERS
5DizzinessFAERS: 8
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
6Chest discomfortFAERS: 7
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
7Device malfunctionFAERS: 7
Canada Vigilance: 4
Canada Vigilance
US FAERS
8AnxietyFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
9Drug dose omissionFAERS: 5US FAERS
10FatigueFAERS: 5
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
SIDER
US FAERS
11Product quality issueFAERS: 5
Canada Vigilance: 4
Canada Vigilance
US FAERS
12VomitingFAERS: 5
Canada Vigilance: 3
Canada Vigilance
US FAERS
13BronchospasmFAERS: 4
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
14NauseaFAERS: 4
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
15NervousnessFAERS: 4US FAERS
16PruritusFAERS: 4
Canada Vigilance: 4
Canada Vigilance
US FAERS
17WheezingFAERS: 4
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
18BlindnessFAERS: 3US FAERS
19CataractFAERS: 3
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
SIDER
US FAERS
20Device FailureFAERS: 3US FAERS
21DysphoniaFAERS: 3
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
SIDER
US FAERS
22MalaiseFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
23NasopharyngitisFAERS: 3OFFSIDES
SIDER
US FAERS
24Throat irritationFAERS: 3
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
25Unevaluable eventFAERS: 3US FAERS
26AnosmiaFAERS: 2
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
27AstheniaFAERS: 2SIDER
US FAERS
28Chest PainFAERS: 2
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
SIDER
US FAERS
29ChillsFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
30Circumstance or information capable of leading to medication errorFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
31DysgeusiaFAERS: 2OFFSIDES
SIDER
US FAERS
32Feeling abnormalFAERS: 2US FAERS
33Macular degenerationFAERS: 2US FAERS
34OverdoseFAERS: 2
Canada Vigilance: 3
Canada Vigilance
US FAERS
35PainFAERS: 2
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
36PalpitationsFAERS: 2SIDER
US FAERS
37PharyngitisFAERS: 2SIDER
US FAERS
38Pulmonary EmbolismFAERS: 2US FAERS
39SyncopeFAERS: 2US FAERS
40ToothacheFAERS: 2US FAERS
41UrticariaFAERS: 2
Canada Vigilance: 4
Canada Vigilance
SIDER
US FAERS
42Visual ImpairmentFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
43AcneFAERS: 1US FAERS
44Alcohol interactionFAERS: 1US FAERS
45Alcohol poisoningFAERS: 1US FAERS
46Allergic sinusitisFAERS: 1US FAERS
47Anaphylactic shockFAERS: 1US FAERS
48Angina PectorisFAERS: 1US FAERS
49AngioedemaFAERS: 1
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
50Angle Closure GlaucomaFAERS: 1US FAERS
51ArthralgiaFAERS: 1SIDER
US FAERS
52ArthropathyFAERS: 1OFFSIDES
US FAERS
53Back PainFAERS: 1SIDER
US FAERS
54Bone painFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
55BronchoscopyFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
56Burning sensationFAERS: 1US FAERS
57Cerebrovascular accidentFAERS: 1US FAERS
58Chronic sinusitisFAERS: 1OFFSIDES
US FAERS
59CryingFAERS: 1
Canada Vigilance: 4
Canada Vigilance
US FAERS
60Deep Vein ThrombosisFAERS: 1US FAERS
61DeformityFAERS: 1US FAERS
62DeliriumFAERS: 1US FAERS
63Device use issueFAERS: 1US FAERS
64DiscomfortFAERS: 1US FAERS
65Disease ProgressionFAERS: 1US FAERS
66Disease recurrenceFAERS: 1US FAERS
67Embolic pneumoniaFAERS: 1US FAERS
68EpistaxisFAERS: 1
Canada Vigilance: 7
Canada Vigilance
SIDER
US FAERS
69Eye painFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
70Failure to ThriveFAERS: 1US FAERS
71FlushingFAERS: 1US FAERS
72General physical health deteriorationFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
73GlaucomaFAERS: 1OFFSIDES
US FAERS
74HemiplegiaFAERS: 1US FAERS
75Incorrect dose administered by deviceFAERS: 1US FAERS
76Incorrect route of drug administrationFAERS: 1US FAERS
77InfectionFAERS: 1OFFSIDES
SIDER
US FAERS
78Intentional device misuseFAERS: 1US FAERS
79Joint stiffnessFAERS: 1OFFSIDES
US FAERS
80Limb injuryFAERS: 1US FAERS
81Lip swellingFAERS: 1
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
82Lower respiratory tract congestionFAERS: 1US FAERS
83LymphomaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
84Medication ErrorFAERS: 1US FAERS
85Migraine with AuraFAERS: 1US FAERS
86Musculoskeletal chest painFAERS: 1SIDER
US FAERS
87MyalgiaFAERS: 1US FAERS
88Nasal discomfortFAERS: 1
Canada Vigilance: 3
Canada Vigilance
OFFSIDES
SIDER
US FAERS
89Oral painFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
90Oropharyngeal painFAERS: 1OFFSIDES
SIDER
US FAERS
91OsteoporosisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
92Pain of skinFAERS: 1US FAERS
93Patent ductus arteriosusFAERS: 1US FAERS
94Personality ChangeFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
95PneumothoraxFAERS: 1OFFSIDES
US FAERS
96PresyncopeFAERS: 1US FAERS
97Product dose omissionFAERS: 1US FAERS
98Product packaging quantity issueFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
99Product substitution issueFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
100Product taste abnormalFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
101Product use in unapproved indicationFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
102Pulmonary FibrosisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
103Pulmonary InfarctionFAERS: 1US FAERS
104Respiratory FailureFAERS: 1US FAERS
105Respiratory tract congestionFAERS: 1OFFSIDES
US FAERS
106Rheumatoid ArthritisFAERS: 1US FAERS
107RhinalgiaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
108SinusitisFAERS: 1OFFSIDES
SIDER
US FAERS
109SomnolenceFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
110TachycardiaFAERS: 1US FAERS
111ThrombosisFAERS: 1US FAERS
112TinnitusFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
113Urinary tract infectionFAERS: 1SIDER
US FAERS
114VasculitisFAERS: 1US FAERS
115VertigoFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
116Vitreous floatersFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
117Vulvovaginal mycotic infectionFAERS: 1US FAERS
118Wrong patient received medicationFAERS: 1US FAERS
119treatment failureFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
120Abnormal weight gainCanada Vigilance: 1Canada Vigilance
121Acute myocardial infarctionOFFSIDES
122Acute respiratory failureOFFSIDES
123Acute sinusitisOFFSIDES
124Adverse eventCanada Vigilance: 1Canada Vigilance
125AgeusiaCanada Vigilance: 1Canada Vigilance
126Alanine Aminotransferase IncreasedSIDER
127Amaurosis FugaxOFFSIDES
128AngioplastyOFFSIDES
129Aortic valve calcificationOFFSIDES
130ApathyOFFSIDES
131AphoniaOFFSIDES
132Atrial FlutterOFFSIDES
133Blood chloride decreasedOFFSIDES
134Blood creatine phosphokinase increasedOFFSIDES
135Body TemperatureOFFSIDES
136BronchitisOFFSIDES
SIDER
137Cardiac FlutterOFFSIDES
138Cardiac asthmaOFFSIDES
139Cataract operationOFFSIDES
140Choking sensationOFFSIDES
141ChokingOFFSIDES
142Concomitant disease progressionOFFSIDES
143Conjunctival depositOFFSIDES
144ConjunctivitisSIDER
145Cortisol decreasedCanada Vigilance: 14Canada Vigilance
146DermatitisSIDER
147Device defectiveCanada Vigilance: 1Canada Vigilance
148DiabetesOFFSIDES
149Diabetes MellitusSIDER
150Drug withdrawal headacheOFFSIDES
151DysgraphiaOFFSIDES
152DysmenorrheaOFFSIDES
153DyspepsiaSIDER
154Erythema MultiformeOFFSIDES
155Escherichia urinary tract infectionOFFSIDES
156Eye irritationCanada Vigilance: 1Canada Vigilance
157Eyelid Function DisorderCanada Vigilance: 1Canada Vigilance
158Foreign body in respiratory tractCanada Vigilance: 1Canada Vigilance
159FractureSIDER
160Gamma-Glutamyltransferase IncreasedSIDER
161GastroenteritisSIDER
162GlossitisOFFSIDES
163Hepatitis COFFSIDES
164HoarsenessSIDER
165Incorrect dose administeredCanada Vigilance: 1Canada Vigilance
166Incorrect route of product administrationCanada Vigilance: 1Canada Vigilance
167Increased upper airway secretionOFFSIDES
168Increased viscosity of bronchial secretionOFFSIDES
169InfestationSIDER
170InfluenzaSIDER
171Infusion site erythemaOFFSIDES
172Infusion site swellingOFFSIDES
173Infusion site urticariaOFFSIDES
174IritisOFFSIDES
175Left atrial dilatationOFFSIDES
176LethargyOFFSIDES
177Leukopenia neonatalOFFSIDES
178Mood swingsCanada Vigilance: 1Canada Vigilance
179Muscle FatigueOFFSIDES
180Muscle strainSIDER
181Musculoskeletal discomfortSIDER
182MyelodysplasiaOFFSIDES
183Nasal passage irritationSIDER
184NephrolithiasisOFFSIDES
185No adverse eventCanada Vigilance: 2Canada Vigilance
186Oral candidiasisSIDER
187Oral fungal infectionSIDER
188Oropharyngeal swellingOFFSIDES
189OsteolysisOFFSIDES
190OsteopeniaSIDER
191Peripheral swellingCanada Vigilance: 1Canada Vigilance
192Pharyngeal candidiasisOFFSIDES
193Pharyngolaryngeal PainSIDER
194PneumoniaCanada Vigilance: 1Canada Vigilance
SIDER
195Polypoidal choroidal vasculopathyOFFSIDES
196Product administration errorCanada Vigilance: 1Canada Vigilance
197Product label issueCanada Vigilance: 1Canada Vigilance
198Product substitutionCanada Vigilance: 1Canada Vigilance
199Product use issueCanada Vigilance: 3Canada Vigilance
200Productive CoughOFFSIDES
201Pulmonary congestionOFFSIDES
202RalesCanada Vigilance: 1Canada Vigilance
203RhinitisSIDER
204Sinus headacheCanada Vigilance: 1Canada Vigilance
SIDER
205Spirometry abnormalCanada Vigilance: 1Canada Vigilance
206SwellingSIDER
207Therapeutic product effect decreasedCanada Vigilance: 2Canada Vigilance
208Therapeutic product ineffectiveCanada Vigilance: 1Canada Vigilance
209TonsillitisSIDER
210UlcerSIDER
211Venous InsufficiencyOFFSIDES
212Viral upper respiratory tract infectionSIDER
213Weight GainOFFSIDES
214Weight decreasedCanada Vigilance: 1Canada Vigilance
215effusionOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120269

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.